These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2427398)

  • 21. Possible involvement of Von Willebrand factor in pancreatic graft thrombosis after kidney-pancreas transplantation: a retrospective study.
    Kessler L; Wiesel ML; Boudjema K; Lutun E; Moulin B; Cazenave JP; Wolf P; Pinget M
    Clin Transplant; 1998 Feb; 12(1):35-42. PubMed ID: 9541421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of heat shock on the expression of urokinase-type plasminogen activator receptor in human umbilical vein endothelial cells.
    Fukao H; Hagiya Y; Ueshima S; Okada K; Takaishi T; Izaki S; Matsuo O
    Thromb Haemost; 1996 Feb; 75(2):352-8. PubMed ID: 8815589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of fibrinolysis in the pathogenesis of the haemorrhagic syndrome produced by virulent isolates of African swine fever virus.
    Villeda CJ; Gómez-Villamandos JC; Williams SM; Hervás J; Wilkinson PJ; Viñuela E
    Thromb Haemost; 1995 Jan; 73(1):112-7. PubMed ID: 7740481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salmeterol enhances pulmonary fibrinolysis in healthy volunteers.
    Maris NA; de Vos AF; Bresser P; van der Zee JS; Jansen HM; Levi M; van der Poll T
    Crit Care Med; 2007 Jan; 35(1):57-63. PubMed ID: 17080003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J
    Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of immortalized human umbilical and iliac vein endothelial cell lines after transfection with SV40 large T-antigen.
    van Leeuwen EB; Veenstra R; van Wijk R; Molema G; Hoekstra A; Ruiters MH; van der Meer J
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):15-25. PubMed ID: 10691096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pathophysiological aspects of the venous system of the leg as a consequence of anatomical and physiological peculairities (author's transl)].
    Jaques R
    Schweiz Rundsch Med Prax; 1975 Oct; 64(40):1282-8. PubMed ID: 1219706
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies on thrombolysis with streptokinase. IV. Immunofluorescent investigations on the fibrin pattern and the content of plasminogen and of plasma-plasmin-inhibitors in clots and thrombi of various age.
    Gottlob R; el-Nashef B; Donas P; Piza F; Kolb R
    Thromb Diath Haemorrh; 1973 May; 29(2):393-407. PubMed ID: 4586907
    [No Abstract]   [Full Text] [Related]  

  • 29. Impaired fibrinolysis in obstructive jaundice--evidence from clinical and experimental studies.
    Colucci M; Altomare DF; Chetta G; Triggiani R; Cavallo LG; Semeraro N
    Thromb Haemost; 1988 Aug; 60(1):25-9. PubMed ID: 3142090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue-type plasminogen activator and fibrin monomers synergistically cause platelet dysfunction during retransfusion of shed blood after cardiopulmonary bypass.
    de Haan J; Schönberger J; Haan J; van Oeveren W; Eijgelaar A
    J Thorac Cardiovasc Surg; 1993 Dec; 106(6):1017-23. PubMed ID: 8246533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective double-arm study of fibrinolysis in surgical patients.
    Kosir MA; Schmittinger L; Barno-Winarski L; Duddella P; Pone M; Perales A; Lange P; Brish LK; McGee K; Beleski K; Pawlak J; Mammen E; Sajahan NP; Kozol RA
    J Surg Res; 1998 Jan; 74(1):96-101. PubMed ID: 9536981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Histologic studies on leg veins in postthrombotic syndrome. Part II:vein wall injury].
    Pavlik F; Kellner G
    Z Hautkr; 1976 Feb; 51(4):163-9. PubMed ID: 9148610
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of 17 beta-estradiol on activity and gene expression of fibrinolytic factor in human umbilical vein endothelial cell].
    Zhang Y; Zhu G; Duan Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Oct; 21(5):326-30. PubMed ID: 12567428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelial-dependent fibrinolysis in subjects with the lupus anticoagulant and thrombosis.
    Francis RB; McGehee WG; Feinstein DI
    Thromb Haemost; 1988 Jun; 59(3):412-4. PubMed ID: 3142079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depression of tissue plasminogen activator (t-PA) activity and rise of t-PA inhibition and acute phase reactants in blood of patients with acute myocardial infarction (AMI).
    Gram J; Kluft C; Jespersen J
    Thromb Haemost; 1987 Oct; 58(3):817-21. PubMed ID: 2448888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Fibrinolytic system and a central retinal vein thrombosis].
    Malukiewicz-Wiśniewska G
    Klin Oczna; 1998; 100(3):175-8. PubMed ID: 9814003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasminogen activator content of human tumor and adjacent normal tissue measured with fibrin and non-fibrin assays.
    Camiolo SM; Greco WR
    Cancer Res; 1986 Apr; 46(4 Pt 1):1788-94. PubMed ID: 3081257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coagulation and fibrinolysis variables in pregnant women with type 1 diabetes mellitus.
    Bronisz A; Rosc D; Bronisz M; Szymanski W; Junik R
    Med Sci Monit; 2008 Nov; 14(11):CR574-9. PubMed ID: 18971874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.
    Johansson JO; Landin K; Johannsson G; Tengborn L; Bengtsson BA
    Thromb Haemost; 1996 Sep; 76(3):422-8. PubMed ID: 8883281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nephrotic syndrome with renal vein thrombosis: pathogenetic importance of a plasmin inhibitor (alpha 2-antiplasmin).
    Du XH; Glas-Greenwalt P; Kant KS; Allen CM; Hayes S; Pollak VE
    Clin Nephrol; 1985 Oct; 24(4):186-91. PubMed ID: 3933871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.